Celldex Therapeutics | CLDX - Cost Of Sales

Stock Price
33.83
Daily Change
0.50 1.50%
Monthly
12.06%
Yearly
90.06%
Q2 Forecast
31.36

Celldex Therapeutics reported $54.2M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Agenus USD 642K 399K Sep/2025
Amgen USD 1.79B 128M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Celldex Therapeutics USD 54.2M 8.94M Jun/2025
Glaxosmithkline GBP 3.47B 461.37M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pfizer USD 6.29B 2.12B Dec/2025
Rigel Pharmaceuticals USD 8.03M 5.22M Sep/2024
Roche Holding CHF 8.48B 4.61B Dec/2025